Genprex Inc. (NASDAQ: GNPX) stock jumped 8.99% on Thursday to $0.85 against a previous-day closing price of $0.78. With 0.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.45 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.8600 whereas the lowest price it dropped to was $0.7450. The 52-week range on GNPX shows that it touched its highest point at $2.67 and its lowest point at $0.72 during that stretch. It currently has a 1-year price target of $5.50. Beta for the stock currently stands at -0.31.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GNPX was up-trending over the past week, with a rise of 11.84%, but this was up by 6.25% over a month. Three-month performance dropped to -37.50% while six-month performance fell -33.07%. The stock lost -46.88% in the past year, while it has lost -41.38% so far this year. A look at the trailing 12-month EPS for GNPX yields -0.49 with Next year EPS estimates of -0.48. For the next quarter, that number is -0.14. This implies an EPS growth rate of -12.80% for this year and 2.00% for next year.
Float and Shares Shorts:
At present, 48.05 million GNPX shares are outstanding with a float of 47.38 million shares on hand for trading. On May 14, 2023, short shares totaled 1.88 million, which was 3.61% higher than short shares on Apr 13, 2023. In addition to Mr. John Rodney Varner as the firm’s Co-Founder, Chairman, Pres & CEO, Mr. Ryan M. Confer M.S. serves as its Chief Financial Officer.
Through their ownership of 7.80% of GNPX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 6.73% of GNPX, in contrast to 4.75% held by mutual funds. Shares owned by individuals account for 13.16%. As the largest shareholder in GNPX with 3.75% of the stake, Armistice Capital LLC holds 1,950,000 shares worth 1,950,000. A second-largest stockholder of GNPX, The Vanguard Group, Inc., holds 1,812,966 shares, controlling over 3.49% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in GNPX, holding 559,235 shares or 1.08% stake. With a 2.17% stake in GNPX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 1,127,694 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 1.15% of GNPX stock, is the second-largest Mutual Fund holder. It holds 598,971 shares valued at 0.49 million. Fidelity Extended Market Index Fu holds 0.48% of the stake in GNPX, owning 250,727 shares worth 0.21 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, GNPX reported revenue of $0.00 and operating income of -$5.18M. The EBITDA in the recently reported quarter was -$5.17M and diluted EPS was -$0.11.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GNPX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GNPX analysts setting a high price target of $3.00 and a low target of $3.00, the average target price over the next 12 months is $3.00. Based on these targets, GNPX could surge 252.94% to reach the target high and rise by 252.94% to reach the target low. Reaching the average price target will result in a growth of 252.94% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded GNPX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 1,676,973 while 0 shares were sold.